Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6450
-0.0150 (-2.27%)
Jun 5, 2026, 3:32 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 223.11 million as of June 5, 2026. Its market cap has increased by 39.11% in one year.
Market Cap
223.11M
Enterprise Value
205.82M
Revenue
86.47M
Ranking
n/a
PE Ratio
60.06
Stock Price
0.65
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 223.11M, a decrease of -44.93%. That is a compound annual growth rate of -9.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 223.11M | -12.62% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 739.20M |
| Imricor Medical Systems | 614.88M |
| EBR Systems | 211.76M |
| EMVision Medical Devices | 157.09M |
| SomnoMed | 131.45M |
| Saluda Medical | 112.15M |
| Lumos Diagnostics Holdings | 97.01M |
| Epiminder | 82.21M |